Equites Radar

PRVA · Privia Health Group, Inc.

Health Information ServicesUnited StatesAnalyst view: Strong Buy

$22.41

-2.08% last session

End-of-day data · close of 2026-10-23

Neutral2 bullish · 2 bearish technical signals
Consensus: Strong Buy (1.39 from 17 analysts)
To mean target: +40.4%

Market cap

$3B

Enterprise value

$3B

Trailing P/E

106.7

Forward P/E

21.1

Dividend yield

0.0%

Beta

0.80

Avg volume

1M

Employees

1K

Daily Change %

-2.08%

5 Days Change

1.62%

10 Days Change

5.70%

30 Days Change

19.82%

60 Days Change

8.87%

Month to Day Change

14.25%

Year to Day Change

-3.48%

Analyst Outlook

Consensus ratingStrong Buy
Recommendation mean (1–5)1.39
Covering analysts17
Mean price target$31.47
Low price target$24.00
Upside to mean target+40.4%

Analyst estimates change daily — follow the shifts on the Estimate Trends page.

Technical Analysis

RSI (14)61.9
50-day MA$20.85
200-day MA$22.70
Price vs 50-day MA+7.5%
Price vs 200-day MA-1.3%
MACD histogram0.21
Volume vs 3-month avg0.5×
52w low $19.1052w high $28.10

Analyst sentiment over time — PRVA

Rec Mean (blue, left — higher = more bullish) vs. price targets (right).

Investment Bank Ratings as of 2026-05-26

Latest call per bank · past 12 months

Barclays

Equal-Weight

$24.00

+7.1% vs price
▼ cut from $25.00Maintains · 2026-05-26

Citigroup

Buy

$32.00

+42.8% vs price
▼ cut from $34.00Maintains · 2026-03-03

JP Morgan

Overweight

$33.00

+47.3% vs price
▲ raised from $32.00Maintains · 2025-11-13

Recent rating actions

DateFirmActionRatingPrice target
2026-05-26BarclaysMaintainsEqual-Weight$25.00 → $24.00
2026-05-08Canaccord GenuityMaintainsBuy$35.00 → $34.00
2026-04-08Evercore ISI GroupMaintainsOutperform$30.00 → $26.00
2026-03-25BarclaysMaintainsEqual-Weight$23.00 → $25.00
2026-03-03CitigroupMaintainsBuy$34.00 → $32.00
2026-03-02Truist SecuritiesMaintainsBuy$31.00 → $33.00
2026-02-27Canaccord GenuityMaintainsBuy$34.00 → $35.00
2025-12-04Stephens & Co.ReiteratesOverweight$32.00

Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.

Signal Summary as of 2026-10-23

  • neutral: RSI (14): RSI is 62 — neutral momentum, neither overbought nor oversold.
  • bullish: Price vs 50-day MA: Trading 7.5% above the 50-day MA ($20.85).
  • bearish: Price vs 200-day MA: Trading 1.3% below the 200-day MA ($22.70).
  • bearish: MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
  • bullish: MACD (12,26,9): MACD histogram is positive (+0.21) — short-term momentum is improving.
  • neutral: 52-week range: Price sits between the 52-week low ($19.10) and high ($28.10).

PRVA Price Chart

Loading chart for PRVA…

Fundamentals

Revenue (TTM)$2.0B
EBITDA$0M
Free cash flow$0M
Operating cash flow$0M
Book value / share$6.20
Net Debt / EBITDA-7.1
WACC10.0%
Revenue growth21.00%
Earnings growth250.00%

About Privia Health Group, Inc.

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.

More in Health Information Services

Screen PRVA against the full market on the Radar →

Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.